You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 6, June 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Frequency of Dementia in Parkinson Disease

Dag Aarsland, MD; Elise Tandberg, MD; Jan P. Larsen, MD, PhD; Jeffrey L. Cummings, MD

Arch Neurol. 1996;53(6):538-542.


Abstract

Objective
To investigate the frequency of dementia in patients with Parkinson disease (PD).

Design
Community-based prevalence study.

Setting
The study population comprised 220 858 inhabitants from the Rogaland County, Norway.

Participants
Almost 400 participants were examined by a neurologist, and 245 were given the diagnosis of PD and included in the study.

Measurements
Mental functioning was rated with the Mini-Mental State Examination; Gottfries, Bråne, and Steen scale; and the intellectual subscale of the Unified Parkinson's Disease Rating Scale. Criteria from the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, were applied during a semistructured interview to determine the diagnosis of dementia.

Results
Dementia was found in 67 patients (27.7%). Patients with dementia were older at the time of the study and at onset of PD and had had PD longer than the patients without dementia. Major depression was more common among patients with dementia (23%) than among patients without dementia (2.3%) ({varkappa}2, P<.001), and patients with dementia were more often institutionalized than those without dementia (62% vs 6%, respectively, {varkappa}2, P<.001). Atypical neurologic features for idiopathic PD (ie, early occurrence of autonomic failure, symmetrical disease presentation, and only moderate response to a dopamine agonist) were associated with more severe dementia of a higher frequency rate and with lower scores on cognitive rating scales.

Conclusion
Approximately one quarter of the patients with PD had dementia with the motor manifestations of PD. Dementia was associated with depression, institutionalization, older age at onset of PD, and atypical neurologic features.



Author Affiliations

From the Section of Geriatric Psychiatry, Psychiatric Hospital in Rogaland (Dr Aarsland), the Department of Neurology, Central Hospital of Rogaland (Drs Larsen and Tandberg), Stavanger, Norway; and the Departments of Neurology and Psychiatry and Biobehavioral Sciences, University of California at Los Angeles School of Medicine, and the Behavioral Neuroscience Section, Psychiatry Service, West Los Angeles Veterans Affairs Medical Center (Dr Cummings).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dementia and survival in Parkinson disease: A 12-year population study
Buter et al.
Neurology 2008;70:1017-1022.
ABSTRACT | FULL TEXT  

Efficacy and Tolerability of Quetiapine in the Treatment of Behavioral and Psychological Symptoms of Dementia
Onor et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;21:448-453.
ABSTRACT  

Differences in neuropathologic characteristics across the Lewy body dementia spectrum
Ballard et al.
Neurology 2006;67:1931-1934.
ABSTRACT | FULL TEXT  

Cognitive Predictors of Dementia in Parkinson's Disease: A Community-Based, 4-Year Longitudinal Study
Janvin et al.
J Geriatr Psychiatry Neurol 2005;18:149-154.
ABSTRACT  

Structural Brain Changes in Parkinson Disease With Dementia: A Voxel-Based Morphometry Study
Summerfield et al.
Arch Neurol 2005;62:281-285.
ABSTRACT | FULL TEXT  

Cerebral atrophy and its relation to cognitive impairment in Parkinson disease
Nagano-Saito et al.
Neurology 2005;64:224-229.
ABSTRACT | FULL TEXT  

Cognitive Dysfunction in Parkinson's Disease: The Role of Frontostriatal Circuitry
Owen
Neuroscientist 2004;10:525-537.
ABSTRACT  

Fluctuations in cognition and alertness in Parkinson's disease and dementia
Serrano and Garcia-Borreguero
Neurology 2004;63:S31-S34.
ABSTRACT | FULL TEXT  

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease
Funkiewiez et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:834-839.
ABSTRACT | FULL TEXT  

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
Walker et al.
Neurology 2004;62:1568-1572.
ABSTRACT | FULL TEXT  

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
Foltynie et al.
Brain 2004;127:550-560.
ABSTRACT | FULL TEXT  

Cortical Lewy body disease
Burn
J. Neurol. Neurosurg. Psychiatry 2004;75:175-178.
FULL TEXT  

Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry
Lewis et al.
J. Neurosci. 2003;23:6351-6356.
ABSTRACT | FULL TEXT  

Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland et al.
Arch Neurol 2003;60:387-392.
ABSTRACT | FULL TEXT  

Enhancement of brain activation during trial-and-error sequence learning in early PD
Mentis et al.
Neurology 2003;60:612-619.
ABSTRACT | FULL TEXT  

Fluctuations in attention: PD dementia vs DLB with parkinsonism
Ballard et al.
Neurology 2002;59:1714-1720.
ABSTRACT | FULL TEXT  

Evaluating drug treatments for Parkinson's disease: how good are the trials?
Wheatley et al.
BMJ 2002;324:1508-1511.
FULL TEXT  

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
Aarsland et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:708-712.
ABSTRACT | FULL TEXT  

Relationships Among the Metabolic Patterns That Correlate With Mnemonic, Visuospatial, and Mood Symptoms in Parkinson's Disease
Mentis et al.
Am. J. Psychiatry 2002;159:746-754.
ABSTRACT | FULL TEXT  

Neuropsychiatry of the basal ganglia
Ring and Serra-Mestres
J. Neurol. Neurosurg. Psychiatry 2002;72:12-21.
ABSTRACT | FULL TEXT  

Parkinson Disease Neuropathology: Later-Developing Dementia and Loss of the Levodopa Response
Apaydin et al.
Arch Neurol 2002;59:102-112.
ABSTRACT | FULL TEXT  

Risk of dementia in Parkinson's disease: A community-based, prospective study
Aarsland et al.
Neurology 2001;56:730-736.
ABSTRACT | FULL TEXT  

Health related quality of life in Parkinson's disease: a prospective longitudinal study
Karlsen et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:584-589.
ABSTRACT | FULL TEXT  

Molecular Etiology of Parkinson Disease: Recent Progress
Shastry
Neuroscientist 2000;6:234-240.
ABSTRACT  

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease
Hurtig et al.
Neurology 2000;54:1916-1921.
ABSTRACT | FULL TEXT  

Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease
Dymek et al.
Neurology 2000;56:17-24.
ABSTRACT | FULL TEXT  

Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease: A Community-Based Study
Aarsland et al.
Arch Neurol 1999;56:595-601.
ABSTRACT | FULL TEXT  

Neuropsychological prediction of dementia in Parkinson's disease
HUGHES et al.
J. Neurol. Neurosurg. Psychiatry 1998;65:804-805.
FULL TEXT  

Parkinson's Disease- First of Two Parts
Lang and Lozano
NEJM 1998;339:1044-1053.
FULL TEXT  

Neuropsychological prediction of dementia in Parkinson's disease
Mahieux et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:178-183.
ABSTRACT | FULL TEXT  

Risk Factors for Depression in Parkinson Disease
Tandberg et al.
Arch Neurol 1997;54:625-630.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.